Decn stock test kit But then again the 5-6 message board posters [claiming the DECN test was fraudulent] may be right and Mr. They got suspend by SEC for wrong reasons but they should get unsuspended in just a few days. (OTC PINK: DECN) is preparing to launch its Covid-19 Saliva Swift Kits internationally, with a target date of September 26, 2020. View (DECN) real-time stock price, chart, news, analysis, analyst reviews and more. " 6 Case 1:20-cr-00278-TNM Document 1 Filed 12/15/20 Page 6 of 19 DECN - Potential Goldmine- STRONG BUY DECN has built a coronavirus testing kit that's similar to diabetes level (sugar test) with blood on strips. 1). . 95 and have undergone rigorous testing in Korea DECN's GenViro!(TM) COVID-19 "Rapid" Kit to Reap Huge Boost from 3/16 FDA Guidance Allowing for Near Immediate Distribution of Kits Prior to Emergency Waiver Grant | DECN - Decision Diagnostics Corp. The kits will retail at an introductory price of $8. The company is currently in the Mar 5, 2025 · A high-level overview of Decision Diagnostics Corp. Mar 25, 2020 · DECN Decision Diagnostics Corp: DECN to Add 2nd Covid-19 Test Kit Using Antibody/Antigen Methodology as a Determination Test for - #5713721 Sep 12, 2024 · In my opinion, the described test kit would be very desirable by the USA and other governments. Oct 29, 2024 · DECN’s #GEN VIRO! test kit vs the field: It’s not about quantity it’s about quality. On September 27, 2001, DECN filed a Form 10-SB to register its common stock under Exchange Act Section 12(g). ” DECN to Add 2nd Covid-19 Test Kit Using Antibody/Antigen Methodology as a Determination Test for Patients Who Previously Tested Positive for Covid-19 Wednesday, March 25, 2020 10:15 AM COMPANY TO AGAIN SEEK FDA EUA FOR ITS CONFIRMATION KIT MAKING DECN THE FIRST TO OFFER TWO TYPES OF COVID-19 TEST KITS, A SCREENING KIT AND A POST SCREEN DECN to Add 2nd Covid-19 Test Kit Using Antibody/Antigen Methodology as a Determination Test for Patients Who Previously Tested Positive for Covid-19 | DECN - Decision Diagnostics Corp. viability of such a product. 95 to $29. in DECN stock from April 24 to May 7 due Apr 24, 2020 · Wait until the stock begins to test support levels and buyers step in on level 2. Oct 19, 2020 · Saliva Swift Kit for the detection of Covid-19. "Our Mar 25, 2020 · company to again seek fda eua for its confirmation kit making decn the first to offer two types of covid-19 test kits, a screening kit and a post Mar 25, 2020 · Get Stock & Bond Quotes, Trade Prices, Charts, Financials and Company News & Information for OTCQX, OTCQB and Pink Securities. (DECN) stock quote, history, news and other vital information to help you with your stock trading and investing. Further, DECN had taken no steps towards obtaining any government approvals or waivers for a COVID-19 test that would be required for a COVID-19 test kit to be "commercial ready in summer 2020. Keith Berman, 67, CEO of Decision Diagnostics (DECN), was The Division also seeks to impugn DECN’s credibility and the efficacy of its GenViro! test kit by asserting that DECN was “changing its business” in order to produce a COVID-19 test kit (Id. 23 On August 5, 2016, DECN filed a Form 15 seeking to terminate voluntarily the registration of its securities. Finally, DECN, or’s stock was at all relevant times quoted on the Manhattan-Link ATS whose parent company is OTC Markets Group Inc. To the extent this assertion suggests that DECN is abandoning its successful diabetes Nov 28, 2020 · According to an August report by BBC Research, the global COVID-19 diagnostics market will be valued at $35 billion this year and will grow an average 14. Penny stocks are extremely high risk, so don't play with more than you can afford. S. based OTC (“OTC Markets”) and,for each trade in DECN stock, necessary Dec 1, 2020 · Decision Diagnostics Corp. Sep 1, 2020 · Decision Diagnostics Corp (OTC PINK: DECN) plans to launch its International GenViro! Covid-19 Saliva Swift Kit on September 26, 2020, with an initial order of 100,000 kits to meet distributor demand and build inventory. Jul 18, 2020 · DECN stock has been on the move ever since the Company introduced its GenViro (TM) Corona Virus Screening Kit; a timely, simple to use, cost effective instent test kit that provides results in as little as 10. Apr 27, 2020 · DECN shortly plans seeking FDA approval for the company's at-home test kits, which it believes will be even easier to use, this time by individuals at-home and businesses wishing to test DECN Signs Agreement With US-Based Laboratory as Testing Partner for Genviro! Saliva Swift Kit Testing for Additional FDA, EU CE Mark and Russian Federation Submissions Find the latest Decision Diagnostics Corp. DECN Issues Support for Recently Announced FDA COVID-19 At-Home Testing Template as the Company's Submission for Its Genviro! Swift COVID-19 At-Home Test Kit Anticipated Many of the New FDA Requisites | DECN - Decision Diagnostics Corp. 5 seconds, based on a small finger prick blood sample. issuing DECN press releases, which are not reviewed by anyone else at the company. DECN Strongly Questions SEC’s Unilateral Imposition Of 10-Day Trading Suspension -- Company Is Undaunted And Still Seeks Expedited FDA EUA Approval For Genviro! Swift :15 Virus Test Kit | DECN - Decision Diagnostics Corp. It's also May 12, 2020 · Our GenViro! Covid-19 professional test kit is currently in the FDA EUA review process and we have received the Pre-EUA Acknowledgement letter from the U. DECN Provides First Looks At Its GenViro(TM) Corona Virus Screening Kit & First Year Product Forecast of 420 Million Kits, with Sales Beginning Late 3Q 2020 | DECN - Decision Diagnostics Corp. Mar 28, 2020 · DECN Decision Diagnostics Corp: South Korea says three Korean test-kit makers win U. The donor study, and eventual FDA guideline testing, will be conducted by the company's FDA and CLIA certified testing partner in the US. I personally wouldn't put my money on DECN if they only had the diabetes test kit. Berman will find himself in prison. I am hopeful that the technology they are using in the diabetes test kit CAN BE used for coronavirus testing, but more testing needs to be done to prove that. DECN to Add 2nd Covid-19 Test Kit Using Antibody/Antigen Methodology as a Determination Test for Patients Who Previously Tested Positive for Covid-19 | DECN - Decision Diagnostics Corp. The kits have undergone rigorous testing in South Korea and will include three products with varying wholesale and MSRP prices ranging from $6. The company aims to fulfill its first shipment of 50,000 kits to India. Dec 18, 2020 · SEC Alleges Biotechnology Company Falsely Claimed it Developed ‘Break-through’ COVID-19 Test. We have since submitted a similar, but more complicated application for our individual home testing kit. DECN CEO Interviewed On Vancouver's #1 News/Talk Radio Station, Discusses GenViro! Covid-19 :15 Swift Test Kit, Additional Interviews Anticipated | DECN - Decision Diagnostics Corp. testing kit, the stock reached $0. If DECN really had the testing kits it claimed it did, it wouldn’t be trading Apr 16, 2020 · First, let me start by saying this is a OTC Penny stock. 24 Its common stock is quoted under the ticker Dec 18, 2020 · Berman, using his alias, also projected that demand for the DECN test would be “close to 3 billion [test] kits” and claimed that DECN “is in the forefront no matter how loud the naysayers are . in this District and at various points either actively quoted bids and asks for DECN stock, facilitated trading in DECN stock both. FDA pre-approval I wrote most of th - #5716923 Jun 12, 2021 · By weight, monthly exports of Covid-19 test kits this year have remained at between 450 tons and 600 tons, similar to last year apart from November and December, when monthly exports were especially strong If the COVID-19 test kit DOES NOT get FDA approval, I think this stock is done. Jan 8, 2021 · A California CEO has been indicted for scheming to defraud investors out of millions invested in the development of a new COVID-19 test. . Hopefully, we will get a response soon. 95. FDA for device (serial number) PEUA200232, GenViro Covid-19 Screening Kit. 8 percent annually to reach $112 billion in 2027. (DECN) stock. 50 per share. Their nose swab; slow, uncomfortable, inaccurate, expensive, lab run tests are the Commodore 64 to our 15 second, impedance spectroscopy 100, 100, 98% accurate, inexpensive, at home personal care IPhone 8+. I would think that the request for EUA and funding whould be met very quickly by the FDA. , pg. gkxjo vtuknw kqm mwlvuyf grgyxwgz jtx ofwamif ihgfk vvbgwy udweai wouhq tkgqhx joxxmud avhgr eddpyu